Jamie Bell

2 weeks ago | neuronewsinternational.com | Jamie Bell

Terumo Neuro has announced the commercial availability of the Sofia 88 neurovascular support catheter in the USA, expanding the company’s stroke portfolio with a new large-bore catheter engineered for reliability, procedural flexibility, and physician control. A company press release notes that this launch builds on the proven clinical performance and global legacy of the Sofia catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade.

2 weeks ago | neuronewsinternational.com | Jamie Bell

Nalu Medical has announced the publication of real-world data in the journal Chronic Pain and Management, describing this as a “significant milestone” that establishes Nalu peripheral nerve stimulation (PNS) as a medically necessary treatment for chronic pain. This analysis includes data from 2,273 patients implanted with the Nalu micro-implantable pulse generator (IPG) PNS system, making it the largest published real-world dataset on a permanent PNS device to date, according to the company.

2 weeks ago | neuronewsinternational.com | Jamie Bell

As per data from the Stroke Services Tracker (SST)—a monitoring tool developed to evaluate progress towards Stroke Action Plan for Europe (SAP-E) targets—improvements are being made with regard to stroke care planning and treatment access, but persistent disparities requiring “urgent attention” remain at play.

2 weeks ago | neuronewsinternational.com | Jamie Bell

A plethora of novel neurovascular devices enjoyed their time in the limelight throughout April, with industry leaders like Penumbra and Terumo Neuro as well as ‘up-and-comers’ including TG Medical, Artedrone and Anaconda Biomed all announcing significant updates over the course of the month. Also featuring are the launch of a ‘world-first’ stroke action movement and an exclusive interview with European Stroke Organisation (ESO) president Simona Sacco (L’Aquila, Italy). 1.

2 weeks ago | neuronewsinternational.com | Jamie Bell

The Brain Aneurysm Foundation (BAF) has been joined by advocates from more than two dozen US states to support ‘Ellie’s Law’—a bipartisan bill recently reintroduced in US congress to increase research funding for brain aneurysm detection and the prevention of ruptures. “Surgical interventions for those diagnosed with a brain aneurysm are highly effective, but only if people know they are at risk prior to a rupture,” said BAF executive director Christine Buckley.